BACKGROUND: Enterohemorrhagic Escherichia coli (EHEC) O26:H11/H-, the most common non-O157 serotype causing hemolytic uremic syndrome worldwide, are evolutionarily highly dynamic with new pathogenic clones emerging rapidly. Here, we investigated the population structure of EHEC O26 isolated from patients in several European countries using whole genome sequencing, with emphasis on a detailed analysis of strains of the highly virulent new European clone (nEC) which has spread since 1990s. RESULTS: Genome-wide single nucleotide polymorphism (SNP)-based analysis of 32 EHEC O26 isolated in the Czech Republic, Germany, Austria and Italy demonstrated a split of the nEC (ST29C2 clonal group) into two distinct lineages, which we termed, based on their temporal emergence, as "early" nEC and "late" nEC. The evolutionary divergence of the early nEC and late nEC is marked by the presence of 59 and 70 lineage-specific SNPs (synapomorphic mutations) in the genomes of the respective lineages. In silico analyses of publicly available E. coli O26 genomic sequences identified the late nEC lineage worldwide. Using a PCR designed to target the late nEC synapomorphic mutation in the sen/ent gene, we identified the early nEC decline accompanied by the late nEC rise in Germany and the Czech Republic since 2004 and 2013, respectively. Most of the late nEC strains harbor one of two major types of Shiga toxin 2a (Stx2a)-encoding prophages. The type I stx2a-phage is virtually identical to stx2a-phage of EHEC O104:H4 outbreak strain, whereas the type II stx2a-phage is a hybrid of EHEC O104:H4 and EHEC O157:H7 stx2a-phages and carries a novel mutation in Stx2a. Strains harboring these two phage types do not differ by the amounts and biological activities of Stx2a produced. CONCLUSIONS: Using SNP-level analyses, we provide the evidence of the evolutionary split of EHEC O26:H11/H- nEC into two distinct lineages, and a recent replacement of the early nEC by the late nEC in Germany and the Czech Republic. PCR targeting the late nEC synapomorphic mutation in ent/sen enables the discrimination of early nEC strains and late nEC strains in clinical and environmental samples, thereby facilitating further investigations of their geographic distribution, prevalence, clinical significance and epidemiology.

Department of Medical Microbiology 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Department of Paediatrics 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Institute for Hygiene and the National Consulting Laboratory on Hemolytic Uremic Syndrome University of Münster Münster Germany

Laboratory for Tissue Cultures National Institute of Public Health Prague Czech Republic

National Reference Center for Salmonella and Other Enteric Pathogens Robert Koch Institute Wernigerode Germany

National Reference Laboratory for E coli and Shigella National Institute of Public Health Prague Czech Republic

See more in PubMed

The European Union summary report on trends and sources of zoonoses Zoonotic agents and food-borne outbreaks in 2016. EFSA J. 2017;15(12):e05077. PubMed PMC

Byrne L, Jenkins C, Launders N, Elson R, Adak GK. The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012. Epidemiol Infect. 2015;143(16):3475–3487. doi: 10.1017/S0950268815000746. PubMed DOI PMC

Caprioli A, Scavia G, Morabito S. Public health microbiology of Shiga toxin-producing PubMed

Elliott EJ, Robins-Browne RM, O'Loughlin EV, Bennett-Wood V, Bourke J, Henning P, Hogg GG, Knight J, Powell H, Redmond D, et al. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child. 2001;85(2):125–131. doi: 10.1136/adc.85.2.125. PubMed DOI PMC

Espié E, Grimont F, Mariani-Kurkdjian P, Bouvet P, Haeghebaert S, Filliol I, Loirat C, Decludt B, Minh NN, Vaillant V, et al. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Pediatr Infect Dis J. 2008;27(7):595–601. doi: 10.1097/INF.0b013e31816a062f. PubMed DOI

Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis. 2002;186(4):493–500. doi: 10.1086/341940. PubMed DOI

Gould LH, Mody RK, Ong KL, Clogher P, Cronquist AB, Garman KN, Lathrop S, Medus C, Spina NL, Webb TH, et al. Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000-2010: epidemiologic features and comparison with E coli O157 infections. Foodborne Pathog Dis. 2013;10(5):453–460. doi: 10.1089/fpd.2012.1401. PubMed DOI

Hedican EB, Medus C, Besser JM, Juni BA, Koziol B, Taylor C, Smith KE. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006. Clin Infect Dis. 2009;49(3):358–364. doi: 10.1086/600302. PubMed DOI

Ishijima N, Lee KI, Kuwahara T, Nakayama-Imaohji H, Yoneda S, Iguchi A, Ogura Y, Hayashi T, Ohnishi M, Iyoda S. Identification of a new virulent clade in enterohemorrhagic Escherichia coli O26:H11/H- sequence type 29. Sci Rep. 2017;7:43136. doi: 10.1038/srep43136. PubMed DOI PMC

Käppeli U, Hächler H, Giezendanner N, Beutin L, Stephan R. Human infections with non-O157 Shiga toxin-producing Escherichia coli, Switzerland, 2000-2009. Emerg Infect Dis. 2011;17(2):180–185. doi: 10.3201/eid1702.100909. PubMed DOI PMC

Karch H, Tarr PI, Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol. 2005;295(6–7):405–418. doi: 10.1016/j.ijmm.2005.06.009. PubMed DOI

Marejková M, Bláhová K, Janda J, Fruth A, Petráš P. Enterohemorrhagic Escherichia coli as causes of hemolytic uremic syndrome in the Czech Republic. PLoS One. 2013;8(9):e73927. doi: 10.1371/journal.pone.0073927. PubMed DOI PMC

Pollock KG, Bhojani S, Beattie TJ, Allison L, Hanson M, Locking ME, Cowden JM. Highly virulent Escherichia coli O26 Scotland. Emerg Infect Dis. 2011;17(9):1777–1779. doi: 10.3201/eid1709.110199. PubMed DOI PMC

Rivas M, Miliwebsky E, Chinen I, Roldán CD, Balbi L, García B, Fiorilli G, Sosa-Estani S, Kincaid J, Rangel J, et al. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina. Foodborne Pathog Dis. 2006;3(1):88–96. doi: 10.1089/fpd.2006.3.88. PubMed DOI

Smith AM, Bosco KJ, Nicol MP, Kleynhans J, McCulloch M, Duze ST, Ismail A, Allam M, Tau NP, Keddy KH. Genome sequence for Shiga toxin-producing Escherichia coli O26:H11, associated with a cluster of hemolytic-uremic syndrome cases in South Africa, 2017. Genome Announc. 2017;5(38):e00989-17. PubMed PMC

Tozzi AE, Caprioli A, Minelli F, Gianviti A, De Petris L, Edefonti A, Montini G, Ferretti A, De Palo T, Gaido M, et al. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg Infect Dis. 2003;9(1):106–108. doi: 10.3201/eid0901.020266. PubMed DOI PMC

Ricotti GC, Buonomini MI, Merlitti A, Karch H, Luzzi I, Caprioli A. A fatal case of hemorrhagic colitis, thrombocytopenia, and renal failure associated with verocytotoxin-producing, non-O157 Escherichia coli. Clin Infect Dis. 1994;19(4):815–816. doi: 10.1093/clinids/19.4.815. PubMed DOI

Rosales A, Hofer J, Zimmerhackl LB, Jungraithmayr TC, Riedl M, Giner T, Strasak A, Orth-Höller D, Würzner R, Karch H, et al. Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis. 2012;54(10):1413–1421. doi: 10.1093/cid/cis196. PubMed DOI

Zieg J, Dusek J, Marejkova M, Limrova P, Blazek D, Pavlicek P, Grega M, Janda J, Blahova K. Fatal case of diarrhea-associated hemolytic uremic syndrome with severe neurologic involvement. Pediatr Int. 2012;54(1):166–167. doi: 10.1111/j.1442-200X.2011.03533.x. PubMed DOI

Zimmerhackl LB, Rosales A, Hofer J, Riedl M, Jungraithmayr T, Mellmann A, Bielaszewska M, Karch H. Enterohemorrhagic Escherichia coli O26:H11-associated hemolytic uremic syndrome: bacteriology and clinical presentation. Semin Thromb Hemost. 2010;36(6):586–593. doi: 10.1055/s-0030-1262880. PubMed DOI

Dallman TJ, Byrne L, Launders N, Glen K, Grant KA, Jenkins C. The utility and public health implications of PCR and whole genome sequencing for the detection and investigation of an outbreak of Shiga toxin-producing Escherichia coli serogroup O26:H11. Epidemiol Infect. 2015;143(8):1672–1680. doi: 10.1017/S0950268814002696. PubMed DOI PMC

Germinario C, Caprioli A, Giordano M, Chironna M, Gallone MS, Tafuri S, Minelli F, Maugliani A, Michelacci V, Santangelo L, et al. Community-wide outbreak of haemolytic uraemic syndrome associated with Shiga toxin 2-producing PubMed PMC

Hines JZ, Bancroft J, Powell M, Hedberg K. Case finding using syndromic surveillance data during an outbreak of Shiga toxin-producing Escherichia coli O26 infections, Oregon 2015. Public Health Rep. 2017;132(4):448–450. doi: 10.1177/0033354917708994. PubMed DOI PMC

Kanayama A, Yahata Y, Arima Y, Takahashi T, Saitoh T, Kanou K, Kawabata K, Sunagawa T, Matsui T, Oishi K. Enterohemorrhagic Escherichia coli outbreaks related to childcare facilities in Japan, 2010-2013. BMC Infect Dis. 2015;15:539. doi: 10.1186/s12879-015-1259-3. PubMed DOI PMC

Luna-Gierke RE, Griffin PM, Gould LH, Herman K, Bopp CA, Strockbine N, Mody RK. Outbreaks of non-O157 Shiga toxin-producing Escherichia coli infection: USA. Epidemiol Infect. 2014;142(11):2270–2280. doi: 10.1017/S0950268813003233. PubMed DOI PMC

Misselwitz J, Karch H, Bielazewska M, John U, Ringelmann F, Rönnefarth G, Patzer L. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11. Pediatr Infect Dis J. 2003;22(4):349–354. PubMed

Moran-Gilad J, Rokney A, Danino D, Ferdous M, Alsana F, Baum M, Dukhan L, Agmon V, Anuka E, Valinsky L, et al. Real-time genomic investigation underlying the public health response to a Shiga toxin-producing Escherichia coli O26:H11 outbreak in a nursery. Epidemiol Infect. 2017;145(14):2998–3006. doi: 10.1017/S0950268817001923. PubMed DOI PMC

Scavia G, Gianviti A, Labriola V, Chiani P, Maugliani A, Michelacci V, Minelli F, Tozzoli R, Caprioli A, Morabito S. A case of haemolytic uraemic syndrome (HUS) revealed an outbreak of Shiga toxin-2-producing PubMed

Severi E, Vial F, Peron E, Mardh O, Niskanen T, Takkinen J. Community-wide outbreaks of haemolytic uraemic syndrome associated with Shiga toxin-producing PubMed PMC

Werber D, Fruth A, Liesegang A, Littmann M, Buchholz U, Prager R, Karch H, Breuer T, Tschäpe H, Ammon A. A multistate outbreak of Shiga toxin-producing Escherichia coli O26:H11 infections in Germany detected by molecular subtyping surveillance. J Infect Dis. 2002;186(3):419–422. doi: 10.1086/341457. PubMed DOI

Bielaszewska M, Mellmann A, Bletz S, Zhang W, Köck R, Kossow A, Prager R, Fruth A, Orth-Höller D, Marejková M, et al. Enterohemorrhagic Escherichia coli O26:H11/H-: a new virulent clone emerges in Europe. Clin Infect Dis. 2013;56(10):1373–1381. doi: 10.1093/cid/cit055. PubMed DOI

Mellmann A, Bielaszewska M, Köck R, Friedrich AW, Fruth A, Middendorf B, Harmsen D, Schmidt MA, Karch H. Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg Infect Dis. 2008;14(8):1287–1290. doi: 10.3201/eid1408.071082. PubMed DOI PMC

Zhang WL, Bielaszewska M, Liesegang A, Tschäpe H, Schmidt H, Bitzan M, Karch H. Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains. J Clin Microbiol. 2000;38(6):2134–2140. PubMed PMC

Delannoy S, Mariani-Kurkdjian P, Bonacorsi S, Liguori S, Ison SA, Fach P. Draft genome sequences of human-pathogenic PubMed PMC

Delannoy S, Mariani-Kurkdjian P, Bonacorsi S, Liguori S, Fach P. Characteristics of emerging human-pathogenic Escherichia coli O26:H11 strains isolated in France between 2010 and 2013 and carrying the stx2d gene only. J Clin Microbiol. 2015;53(2):486–492. doi: 10.1128/JCM.02290-14. PubMed DOI PMC

Grande L, Michelacci V, Bondì R, Gigliucci F, Franz E, Badouei MA, Schlager S, Minelli F, Tozzoli R, Caprioli A, et al. Whole-genome characterization and strain comparison of VT2f-producing Escherichia coli causing hemolytic uremic syndrome. Emerg Infect Dis. 2016;22(12):2078–2086. doi: 10.3201/eid2212.160017. PubMed DOI PMC

Bletz S, Bielaszewska M, Leopold SR, Köck R, Witten A, Schuldes J, Zhang W, Karch H, Mellmann A. Evolution of enterohemorrhagic Escherichia coli O26 based on single-nucleotide polymorphisms. Genome Biol Evol. 2013;5(10):1807–1816. doi: 10.1093/gbe/evt136. PubMed DOI PMC

Delannoy S, Mariani-Kurkdjian P, Webb HE, Bonacorsi S, Fach P. The mobilome; a major contributor to Escherichia coli stx2-positive O26:H11 strains intra-serotype diversity. Front Microbiol. 2017;8:1625. doi: 10.3389/fmicb.2017.01625. PubMed DOI PMC

Ogura Y, Gotoh Y, Itoh T, Sato MP, Seto K, Yoshino S, Isobe J, Etoh Y, Kurogi M, Kimata K, et al. Population structure of PubMed PMC

Nataro JP, Seriwatana J, Fasano A, Maneval DR, Guers LD, Noriega F, Dubovsky F, Levine MM, Morris JG. Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains. Infect Immun. 1995;63(12):4721–4728. PubMed PMC

Krüger A, Lucchesi PM. Shiga toxins and stx phages: highly diverse entities. Microbiology. 2015;161(Pt 3):451–462. doi: 10.1099/mic.0.000003. PubMed DOI

Laing CR, Zhang Y, Gilmour MW, Allen V, Johnson R, Thomas JE, Gannon VP. A comparison of Shiga-toxin 2 bacteriophage from classical enterohemorrhagic Escherichia coli serotypes and the German E. coli O104:H4 outbreak strain. PLoS One. 2012;7(5):e37362. doi: 10.1371/journal.pone.0037362. PubMed DOI PMC

Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W, et al. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One. 2011;6(7):e22751. doi: 10.1371/journal.pone.0022751. PubMed DOI PMC

Hayashi T, Makino K, Ohnishi M, Kurokawa K, Ishii K, Yokoyama K, Han CG, Ohtsubo E, Nakayama K, Murata T, et al. Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res. 2001;8(1):11–22. doi: 10.1093/dnares/8.1.11. PubMed DOI

Perna NT, Plunkett G, Burland V, Mau B, Glasner JD, Rose DJ, Mayhew GF, Evans PS, Gregor J, Kirkpatrick HA, et al. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature. 2001;409(6819):529–533. doi: 10.1038/35054089. PubMed DOI

Ogura Y, Mondal SI, Islam MR, Mako T, Arisawa K, Katsura K, Ooka T, Gotoh Y, Murase K, Ohnishi M, et al. The Shiga toxin 2 production level in enterohemorrhagic Escherichia coli O157:H7 is correlated with the subtypes of toxin-encoding phage. Sci Rep. 2015;5:16663. doi: 10.1038/srep16663. PubMed DOI PMC

Allerberger F, Friedrich AW, Grif K, Dierich MP, Dornbusch HJ, Mache CJ, Nachbaur E, Freilinger M, Rieck P, Wagner M, et al. Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milk. Int J Infect Dis. 2003;7(1):42–45. doi: 10.1016/S1201-9712(03)90041-5. PubMed DOI

Zweifel C, Cernela N, Stephan R. Detection of the emerging Shiga toxin-producing Escherichia coli O26:H11/H- sequence type 29 (ST29) clone in human patients and healthy cattle in Switzerland. Appl Environ Microbiol. 2013;79(17):5411–5413. doi: 10.1128/AEM.01728-13. PubMed DOI PMC

Zhou K, Ferdous M, de Boer RF, Kooistra-Smid AM, Grundmann H, Friedrich AW, Rossen JW: The mosaic genome structure and phylogeny of Shiga toxin-producing PubMed

Beutin L, Hammerl JA, Reetz J, Strauch E. Shiga toxin-producing Escherichia coli strains from cattle as a source of the Stx2a bacteriophages present in enteroaggregative Escherichia coli O104:H4 strains. Int J Med Microbiol. 2013;303(8):595–602. doi: 10.1016/j.ijmm.2013.08.001. PubMed DOI

Garred O, van Deurs B, Sandvig K. Furin-induced cleavage and activation of Shiga toxin. J Biol Chem. 1995;270(18):10817–10821. doi: 10.1074/jbc.270.18.10817. PubMed DOI

Fagerquist CK, Sultan O. Top-down proteomic identification of furin-cleaved α-subunit of Shiga toxin 2 from Escherichia coli O157:H7 using MALDI-TOF-TOF-MS/MS. J Biomed Biotechnol. 2010;2010:123460. doi: 10.1155/2010/123460. PubMed DOI PMC

Li XP, Tumer NE. Differences in ribosome binding and sarcin/ricin loop depurination by Shiga and ricin holotoxins. Toxins (Basel). 2017;9(4) PubMed PMC

Tian S. A 20 residues motif delineates the furin cleavage site and its physical properties may influence viral fusion. Biochemistry Insights. 2009;2:BCI.S2049. doi: 10.4137/BCI.S2049. DOI

Benson DA, Cavanaugh M, Clark K, Karsch-Mizrachi I, Ostell J, Pruitt KD, Sayers EW. GenBank. Nucleic Acids Res. 2018;46(D1):D41–D47. doi: 10.1093/nar/gkx1094. PubMed DOI PMC

Gabrielsen C, Drabløs F, Afset JE. Genome sequences of 11 Shiga toxin-producing PubMed PMC

Mellmann A, Bletz S, Böking T, Kipp F, Becker K, Schultes A, Prior K, Harmsen D. Real-time genome sequencing of resistant bacteria provides precision infection control in an institutional setting. J Clin Microbiol. 2016;54(12):2874–2881. doi: 10.1128/JCM.00790-16. PubMed DOI PMC

Tatusova T, DiCuccio M, Badretdin A, Chetvernin V, Nawrocki EP, Zaslavsky L, Lomsadze A, Pruitt KD, Borodovsky M, Ostell J. NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res. 2016;44(14):6614–6624. doi: 10.1093/nar/gkw569. PubMed DOI PMC

Kaas RS, Leekitcharoenphon P, Aarestrup FM, Lund O. Solving the problem of comparing whole bacterial genomes across different sequencing platforms. PLoS One. 2014;9(8):e104984. doi: 10.1371/journal.pone.0104984. PubMed DOI PMC

Price MN, Dehal PS, Arkin AP. FastTree 2--approximately maximum-likelihood trees for large alignments. PLoS One. 2010;5(3):e9490. doi: 10.1371/journal.pone.0009490. PubMed DOI PMC

Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870–1874. doi: 10.1093/molbev/msw054. PubMed DOI PMC

Boratyn GM, Camacho C, Cooper PS, Coulouris G, Fong A, Ma N, Madden TL, Matten WT, McGinnis SD, Merezhuk Y, et al. BLAST: a more efficient report with usability improvements. Nucleic Acids Res. 2013;41(Web Server issue):W29–W33. doi: 10.1093/nar/gkt282. PubMed DOI PMC

Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, Buxton S, Cooper A, Markowitz S, Duran C, et al. Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics. 2012;28(12):1647–1649. doi: 10.1093/bioinformatics/bts199. PubMed DOI PMC

Darling AE, Mau B, Perna NT. progressiveMauve: multiple genome alignment with gene gain loss and rearrangement. PLoS One. 2010;5(6):e11147. doi: 10.1371/journal.pone.0011147. PubMed DOI PMC

Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403–410. doi: 10.1016/S0022-2836(05)80360-2. PubMed DOI

Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012;13:134. doi: 10.1186/1471-2105-13-134. PubMed DOI PMC

Bauwens A, Bielaszewska M, Kemper B, Langehanenberg P, von Bally G, Reichelt R, Mulac D, Humpf HU, Friedrich AW, Kim KS, et al. Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells. Thromb Haemost. 2011;105(3):515–528. doi: 10.1160/TH10-02-0140. PubMed DOI

Ogura Y, Ooka T, Iguchi A, Toh H, Asadulghani M, Oshima K, Kodama T, Abe H, Nakayama K, Kurokawa K, et al. Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc Natl Acad Sci U S A. 2009;106(42):17939–17944. doi: 10.1073/pnas.0903585106. PubMed DOI PMC